Avricore Health Inc

Healthcare CA AVCR

0.055CAD
0.00(0%)

Last update at 2026-06-23T17:58:00Z

Day Range

0.060.06

LowHigh

52 Week Range

0.040.10

LowHigh

Fundamentals

Previous Close 0.06
Market Cap6.08M
Volume85830
P/E Ratio-
Dividend Yield-%
EBITDA-0.57803M
Revenue TTM1.92M
Revenue Per Share TTM0.02
Gross Profit TTM 0.84M
Diluted EPS TTM-0.02

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Income before tax	-0.66898M	-0.70122M	-0.81823M	-1.70813M	-1.17397M
Minority interest	-	-	-	-	-
Net income	-0.66898M	-0.70122M	-0.81823M	-1.70813M	-1.17397M
Selling general administrative	1.69M	1.84M	1.01M	1.71M	0.85M
Selling and marketing expenses	-	-	0.18M	-	0.00228M
Gross profit	1.88M	1.20M	0.46M	0.03M	0.02M
Reconciled depreciation	0.45M	0.42M	0.18M	0.02M	0.07M
Ebit	-	-	-0.80986M	-1.74501M	-0.97767M
Ebitda	-	-	-0.62681M	-1.72702M	-0.85915M
Depreciation and amortization	-	-	0.18M	0.02M	0.12M
Non operating income net other	-	-	-	-	-
Operating income	0.14M	-0.68724M	-0.80986M	-1.74501M	-0.85915M
Other operating expenses	-	-	2.58M	1.86M	0.89M
Interest expense	-	0.00000M	0.00542M	0.04M	0.16M
Tax provision	-	-	-	-	-
Interest income	0.00123M	0.00328M	0.00809M	0.00058M	0.00000M
Net interest income	-0.00911M	-0.00272M	0.00266M	-0.04466M	-0.16486M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	-	0.04M	0.04M
Total revenue	4.79M	3.49M	1.77M	0.12M	0.03M
Total operating expenses	4.65M	4.17M	1.27M	1.77M	0.87M
Cost of revenue	2.91M	2.28M	1.31M	0.09M	0.02M
Total other income expense net	-0.79921M	-0.01125M	-0.00837M	0.08M	-0.15586M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-0.66898M	-0.70122M	-0.81823M	-1.70813M	-1.17397M
Net income applicable to common shares	-	-	-	-1.70813M	-1.17397M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Total assets	2.30M	2.54M	2.57M	2.28M	0.44M
Intangible assets	0.06M	0.05M	0.03M	0.03M	0.00000M
Earning assets	-	-	-	-	-
Other current assets	-	-	-	0.01M	0.06M
Total liab	0.33M	0.53M	0.60M	0.08M	1.15M
Total stockholder equity	1.97M	2.01M	1.96M	2.20M	-0.71404M
Deferred long term liab	-	-	-	-	-
Other current liab	-	-	-	-	-
Common stock	-	-	-	26.62M	22.29M
Capital stock	27.30M	27.19M	27.06M	26.62M	22.29M
Retained earnings	-32.40454M	-31.73556M	-31.03434M	-30.21612M	-28.50799M
Other liab	-	-	-	-	-
Good will	-	-	-	-	-
Other assets	-	-	-	-	-
Cash	1.13M	0.28M	0.62M	2.01M	0.30M
Cash and equivalents	-	-	-	-	-
Total current liabilities	0.33M	0.53M	0.60M	0.08M	1.15M
Current deferred revenue	-	-	-	-	-
Net debt	-	-	-	-	0.70M
Short term debt	-	-	-	-	-
Short long term debt	-	0.04M	0.04M	0.04M	1.00M
Short long term debt total	-	-	-	-	-
Other stockholder equity	-	-	-	5.79M	5.51M
Property plant equipment	-	-	-	0.09M	-
Total current assets	1.58M	0.77M	1.43M	2.16M	0.44M
Long term investments	-	-	-	-	-
Net tangible assets	-	-	-	2.17M	-0.71404M
Short term investments	0.01000M	0.01000M	0.01000M	-	-
Net receivables	0.41M	0.42M	0.75M	0.09M	0.01M
Long term debt	-	-	-	-	-
Inventory	0.00051M	0.02M	-	-	-
Accounts payable	0.26M	0.43M	0.26M	0.04M	0.13M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	-	-
Deferred long term asset charges	-	-	-	-	-
Non current assets total	0.72M	1.76M	1.14M	0.12M	0.00000M
Capital lease obligations	-	-	-	-	0.00000M
Long term debt total	-	-	-	-	-

Breakdown	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Investments	0.00000M	-1.04686M	-1.20852M	-0.14036M	-0.00430M
Change to liabilities	-	-	-	-0.06959M	-0.33904M
Total cashflows from investing activities	-	-	-	-0.14036M	-0.14036M
Net borrowings	-0.03000M	-	-	-1.00000M	0.93M
Total cash from financing activities	0.06M	0.04M	0.25M	3.08M	1.51M
Change to operating activities	-	-	-	0.07M	0.05M
Net income	-0.66898M	-0.70122M	-0.81823M	-1.70813M	-1.17397M
Change in cash	0.86M	-0.34396M	-1.39247M	1.71M	0.29M
Begin period cash flow	0.28M	0.62M	2.01M	0.30M	0.01M
End period cash flow	1.13M	0.28M	0.62M	2.01M	0.30M
Total cash from operating activities	1.00M	0.66M	-0.43783M	-1.23415M	-1.22340M
Issuance of capital stock	-	0.00000M	0.00000M	2.40M	0.63M
Depreciation	0.45M	0.42M	0.18M	0.02M	0.01M
Other cashflows from investing activities	-	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	0.02M	-0.02068M	-0.26842M	0.07M	-0.18043M
Change to account receivables	0.00810M	0.34M	-0.68749M	-0.07962M	0.00355M
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	-	-	0.25M	1.68M	0.90M
Change to netincome	-	-	-	0.53M	0.42M
Capital expenditures	0.21M	1.05M	1.20M	0.14M	0.11M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	-0.11198M	0.23M	-0.14284M	-0.07823M	-0.47067M
Stock based compensation	0.54M	0.70M	0.33M	0.50M	0.13M
Other non cash items	-	-0.00000M	0.00867M	0.04M	0.29M
Free cash flow	0.80M	-0.38646M	-1.63635M	-1.37452M	-1.22340M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
AVCR Avricore Health Inc	- -%	0.06	-	-	3.16	5.09	3.30	41.13
JUMP Leveljump Healthcare Corp	- -%	0.06	3.50	-	0.36	1.00	0.82	8.59
TELO Telo Genomics Corp	- -%	0.04	-	-	-	8.78	-6.3236
ARC Arian Resources Corp.	- -%	0.01	-	-	2.12	-	15.59	2.25
MBI-H Med BioGene Inc	- -%	0.03	-	-	-	-	-3.032

Reports Covered

View All

Profile

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Avricore Health Inc

789 West Pender Street, Vancouver, BC, Canada, V6C 1H2

604 773 8943
https://avricore.com

Key Executives

Name	Title	Year Born
Mr. Hector Bremner	CEO & Director	1982
Ms. Kiriaki Smith CPA, CFO, CGA, CPA	CFO & Corp. Sec.	1967
Mr. Rodger Seccombe	Head of Healthtab Division & Director	1981
Mr. Will Seccombe	Communications Advisor	NA
Dr. Allan Shapiro	Mang. of Bus. Devel.	NA
Ms. Kiriaki Smith CPA, CFO, CGA, CPA	CFO & Corporate Secretary	1967
Mr. Rodger Seccombe	CTO & Director	1981
Mr. Rodger Seccombe	CEO, CTO & Director	1981
Ms. Kiriaki Smith CPA, CFO, CGA	CFO & Corporate Secretary	1967

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.